VS-4718

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameVS-4718
Drug Alias NameVS-4718PND-1186
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFocal adhesion kinase 1 inhibitors
TargetsFocal adhesion kinase 1
Therapy Area/IndicationsNeoplasm MetastasisPancreatic NeoplasmsLeukemia, Myeloid, Acute +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVerastem Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVerastem Inc
Active IndicationsN/A
Inactive IndicationsNeoplasm MetastasisPancreatic NeoplasmsLeukemia, Myeloid, Acute +[5] 

Other Information

ATC CodeN/A
Related LinksN/A